Eagle Bay Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-162
Closed -$15K 368
2024
Q4
$15K Buy
162
+22
+16% +$2.16K 0.01% 509
2024
Q3
$13.5K Buy
140
+39
+39% +$3.5K 0.01% 716
2024
Q2
$8.66K Sell
101
-61
-38% -$5.12K 0.01% 586
2024
Q1
$13.4K Sell
162
-30
-16% -$2.2K 0.01% 510
2023
Q4
$12.8K Sell
192
-1,346
-88% -$87.2K 0.01% 480
2023
Q3
$103K Buy
1,538
+300
+24% +$20.6K 0.05% 240
2023
Q2
$83.8K Sell
1,238
-113
-8% -$7.08K 0.05% 257
2023
Q1
$73.1K Sell
1,351
-196
-13% -$11.4K 0.04% 308
2022
Q4
$92.5K Buy
1,547
+871
+129% +$47.4K 0.05% 252
2022
Q3
$30K Sell
676
-605
-47% -$30.3K 0.02% 444
2022
Q2
$57.1K Buy
1,281
+742
+138% +$38.1K 0.03% 331
2022
Q1
$31K Sell
539
-118
-18% -$6.16K 0.03% 194
2021
Q4
$34K Buy
657
+67
+11% +$3.46K 0.02% 464
2021
Q3
$35K Buy
590
+36
+6% +$2.27K 0.02% 487
2021
Q2
$37K Buy
+554
New +$36.9K 0.03% 411

Other funds holding EHC

Eagle Bay Advisors's EHC Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 162 shares — an estimated $15K sold.

Eagle Bay Advisors first reported a position in EHC in Q2 2021 and held it in 15 quarters. The position peaked at $103K in Q3 2023. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 162 Encompass Health shares in Q1 2025, an estimated $15K.
  • Eagle Bay Advisors first reported a position in Encompass Health in Q2 2021 and held it in 15 quarters.
  • Eagle Bay Advisors's Encompass Health position peaked at $103K in Q3 2023.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.